In these studies, adenocarcinoma, squamous cell carcinoma and other NSCLC histologies were jointly analyzed, which may explain that no prognostic potential could be reported for p53 immunostaining, consistent with our analysis for the entire cohort. This evidence concerns the gene TP53 and adenocarcinoma.